siRNA‐cell‐penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Controlled Release"
DOI: 10.1016/j.jconrel.2016.11.027
Abstract: &NA; Chronic myeloid leukemia (CML) is a myeloproliferative disorder caused by a single gene mutation, a reciprocal translocation that originates the Bcr‐Abl gene with constitutive tyrosine kinase activity. As a monogenic disease, it is an… read more here.
Keywords: bcr abl; bv173 cell; cell; sirna ... See more keywords